✦ LIBER ✦

Clinical significance of serum hepatocyte growth factor and epidermal growth factor gene somatic mutations in patients with non-squamous non-small cell lung cancer receiving gefitinib or erlotinib

✍ Scribed by Katsuhiro Masago, Yosuke Togashi, Shiro Fujita, Yuichi Sakamori, Chiyuki Okuda, Young Hak Kim, Tadashi Mio, Michiaki Mishima

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical significance of pretreatment se

✍ Katsuhiro Masago; Shiro Fujita; Yukimasa Hatachi; Akiko Fukuhara; Keiichiro Saku 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Clinical predictors versus epidermal gro

✍ Han, Sae-Won; Kim, Tae-You; Lee, Kyung-Hun; Hwang, Pil Gyu; Jeon, Yoon Kyung; Oh 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 332 KB

Mutations in the epidermal growth factor

✍ David F. Heigener; Martin Reck 📂 Article 📅 2010 🏛 Springer Healthcare Communications 🌐 English ⚖ 180 KB

Prospective phase II study of gefitinib

✍ Sugio, Kenji; Uramoto, Hidetaka; Onitsuka, Takamitsu; Mizukami, Makiko; Ichiki, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Epidermal growth factor receptor polymor

✍ Liu, G; Gurubhagavatula, S; Zhou, W; Wang, Z; Yeap, B Y; Asomaning, K; Su, L; He 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

Epidermal Growth Factor Receptor Gene Mu

✍ Takano, T. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 277 KB